Polypharmacy-Induced Long QT Syndrome in a Patient With Newly Diagnosed Acute Myeloid Leukaemia: A Case Report

被引:1
作者
Khan, Zahid [1 ,2 ,3 ,4 ]
机构
[1] Mid & South Essex NHS Natl Hlth Serv Fdn Trust, Acute Med, Southend On Sea, England
[2] Barts Heart Ctr, Cardiol, London, England
[3] Barking Havering & Redbridge Univ Hosp NHS Natl H, Cardiol & Gen Med, London, England
[4] Royal Free Hosp, Cardiol, London, England
关键词
electrolyte imbalance; chemotherapy response; life-threatening arrhythmia; ventricular tachycardia (vt); severe sepsis; ecg interpretation; rational polypharmacy; long qtc; leukaemia; acute myeloid leukaemia; PROLONGATION;
D O I
10.7759/cureus.36914
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Long QT syndrome is a type of disease caused by ion channels in the heart not working properly. It is a rare condition that can affect up to one in 2000 people. Many people with this condition do not develop any symptoms; however, this can lead to heart rhythm abnormality, known as torsades de pointes, and can sometimes be fatal. The cause of this condition is often inherited; however, it can also be triggered by certain medications. But the latter tends to affect those who already tend to develop this condition. The medications causing this condition include antiarrhythmics, antibiotics, antihistamines, antiemetics, antidepressants, antipsychotics, and many more. In this case report, we will be discussing a 63-year-old female who developed long QT syndrome as a result of the multiple drug therapy which is associated with long QT syndrome. Our patient was admitted to the hospital with dyspnoea, fatigue, and weight loss and was diagnosed with acute myeloid leukaemia. The patient was commenced on several medications leading to a prolonged QTc interval which resolved after stopping the culprit medications.
引用
收藏
页数:7
相关论文
共 7 条
  • [1] QT Prolongation, Torsades de Pointes, and Psychotropic Medications: A 5-Year Update
    Beach, Scott R.
    Celano, Christopher M.
    Sugrue, Alan M.
    Adams, Caitlin
    Ackerman, Michael J.
    Noseworthy, Peter A.
    Huffman, Jeff C.
    [J]. PSYCHOSOMATICS, 2018, 59 (02) : 105 - 122
  • [2] Cancer Treatment-Induced Arrhythmias Focus on Chemotherapy and Targeted Therapies
    Buza, Vitaly
    Rajagopalan, Bharath
    Curtis, Anne B.
    [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2017, 10 (08)
  • [3] QT Assessment in Early Drug Development: The Long and the Short of It
    Lester, Robert M.
    Paglialunga, Sabina
    Johnson, Ian A.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (06):
  • [4] Li Matthew, 2017, P T, V42, P473
  • [5] Drug-induced QT interval prolongation: mechanisms and clinical management
    Nachimuthu, Senthil
    Assar, Manish D.
    Schussler, Jeffrey M.
    [J]. THERAPEUTIC ADVANCES IN DRUG SAFETY, 2012, 3 (05) : 241 - 253
  • [6] Long-QT Syndrome From Genetics to Management
    Schwartz, Peter J.
    Crotti, Lia
    Insolia, Roberto
    [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2012, 5 (04) : 868 - 877
  • [7] Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trials
    Wisniowska, Barbara
    Tylutki, Zofia
    Wyszogrodzka, Gabriela
    Polak, Sebastian
    [J]. BMC PHARMACOLOGY & TOXICOLOGY, 2016, 17